Upgrade to SI Premium - Free Trial

Oncolytics Biotech (ONCY)

0.81 +0.06 (8.00%)

Chart
Today 6M 1Y 5Y

Upcoming Events

- Earnings (8/10/26 *Est.)

Latest Headlines

Three Nasdaq Cancer Developers Under $10 Advance Clinical Programs September 11, 2026 8:45 AM - StreetInsider Form 8-K ONCOLYTICS BIOTECH INC For: Sep 10 September 10, 2026 8:18 AM - SEC Filing Oncolytics reports preclinical data on pelareorep with RAS inhibitor September 10, 2026 8:15 AM - StreetInsider Oncolytics Biotech® Announces Positive Preclinical Results Combining Pelareorep with a Pan-RAS Inhibitor in Colorectal Cancer September 10, 2026 8:15 AM - Globe NewsWire Oncolytics Biotech (ONCY) PT Lowered to $5 at H.C. Wainwright August 19, 2026 6:43 AM - StreetInsider Form 8-K ONCOLYTICS BIOTECH INC For: Aug 18 August 18, 2026 9:03 AM - SEC Filing Oncolytics gets FDA feedback on colorectal cancer trial expansion August 18, 2026 9:01 AM - StreetInsider Oncolytics Biotech® Aligns with FDA on Registrational Path for Second-Line RAS-Mutant MSS Colorectal Cancer August 18, 2026 9:00 AM - Globe NewsWire Form 10-Q ONCOLYTICS BIOTECH INC For: Jun 30 August 12, 2026 4:19 PM - SEC Filing Form 8-K ONCOLYTICS BIOTECH INC For: Jul 20 July 24, 2026 4:40 PM - SEC Filing Form 8-K ONCOLYTICS BIOTECH INC For: Jul 20 July 20, 2026 9:03 AM - SEC Filing FDA grants fast track status to Oncolytics' pelareorep for anal cancer July 20, 2026 9:01 AM - StreetInsider Oncolytics Biotech® Receives Fast Track Designation for Pelareorep in Second-Line and Later Anal Cancer July 20, 2026 9:00 AM - Globe NewsWire H.C. Wainwright Reiterates Buy Rating on Oncolytics Biotech (ONCY) July 14, 2026 7:00 AM - StreetInsider Form 8-K ONCOLYTICS BIOTECH INC For: Jul 13 July 13, 2026 9:04 AM - SEC Filing Oncolytics to meet FDA on registrational path for REO 033 trial July 13, 2026 9:01 AM - StreetInsider Oncolytics Biotech® Reports FDA Regulatory Milestone and Strong Clinical Progress in Randomized RAS-Mutant MSS Colorectal Cancer Trial July 13, 2026 9:00 AM - Globe NewsWire Form 8-K ONCOLYTICS BIOTECH INC For: Jul 06 July 8, 2026 4:23 PM - SEC Filing Form 8-K ONCOLYTICS BIOTECH INC For: Jun 16 June 16, 2026 9:05 AM - SEC Filing ONCY secures U.S. patent for pelareorep manufacturing through 2044 June 16, 2026 9:00 AM - StreetInsider Oncolytics Biotech® Secures New U.S. Patent Protecting Commercial Manufacturing of Pelareorep into 2044 June 16, 2026 9:00 AM - Globe NewsWire Full Article List